Drugs / MF59-adjuvanted H5N1 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00311480 | Mar 2006 → ? | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-adjuvanted H5N1 vaccine | “MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults.” PMID 19197383 ↗ Feb 2009 |
| Known as | MF59-adjuvanted influenza H5N1 vaccine | “Both formulations of MF59-adjuvanted influenza H5N1 vaccine were well tolerated.” PMID 19197383 ↗ Feb 2009 |
| Modality | Vaccine | “subunit MF59-adjuvanted H5N1 (A/Vietnam/1194/2004) (clade 1) vaccine” PMID 19197383 ↗ Feb 2009 |